Intent to Sole Source Good Manufacturing Practices (GMP) Influenza A Primer Kits
75D301-26-Q-78825 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Petaluma, CA, with responses due 2026-02-09. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The Center for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases Influenza Division (NCIRD/ID), intends to award a sole source, firm fixed price purchase order in accordance with FAR 13.101(b), soliciting from a single source, to Biosearch Technologies I
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
| BECTON, DICKINSON AND COMPANY | $21K | 1 | 2026-07-01 |
| CEPHEID | $306K | n/a | 2026-07-01 |
Questions
What is solicitation 75D301-26-Q-78825?
Intent to Sole Source Good Manufacturing Practices (GMP) Influenza A Primer Kits, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Petaluma, CA. Responses are due 2026-02-09.
What do similar contracts close for?
Comparable closed awards in this category ran from $21K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.